PATENT CLAIM ANALYSIS

Application Number: 15862856
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["514", "183000"]

Abstract:
Methods and formulations for treating onocological disorders in humans using Coenzyme Q10 are described.

Claim (Index 13):
The method of  claim 1 , wherein the treatment occurs via an interaction of Coenzyme Q10 with a protein selected from the group consisting of HNF4-alpha, Bcl-xl, Bcl-xS, BNIP-2, Bcl-2, Birc6, Bcl-2-L11 (Bim), XIAP, BRAF, Bax, c-Jun, Bmf, PUMA, cMyc, transaldolase 1, COQ1, COQ3, COQ6, prenyltransferase, 4-hydrobenzoate, neutrophil cytosolic factor 2, nitric oxide synthase 2A, superoxide dismutase 2, VDAC, Bax channel, ANT, Cytochrome c, complex 1, complex II, complex III, complex IV, Foxo 3a, DJ-1, IDH-1, Cpt1C, and Cam Kinase II and any one or more of genes listed in Tables 2-4 & 6-28.

Metadata:
- Claim Count in Document: 63.0
- Percentile: 86.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14171419', '12777902', '12778029', '14705591', '10597378']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8415980175911484
- 35 USC 102 Novelty (BERT): 0.6943021645046914
- Combined Prediction Score: 0.8268684322825026
- Mean Citation Score: 462.318296
- Max Citation Score: 701.85266
- Similarity Product: 691.918918374555

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test